Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Thomas J. Novitsky"'
Autor:
Thomas J. Novitsky
Publikováno v:
International Horseshoe Crab Conservation and Research Efforts: 2007-2020 ISBN: 9783030823146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::139294ec137c2db5a21cb14600100d94
https://doi.org/10.1007/978-3-030-82315-3_20
https://doi.org/10.1007/978-3-030-82315-3_20
Autor:
Thomas J. Novitsky
Publikováno v:
Changing Global Perspectives on Horseshoe Crab Biology, Conservation and Management ISBN: 9783319195414
North American horseshoe crabs (Limulus polyphemus) have been continuously harvested in Massachusetts for the production of Limulus amebocyte lysate (LAL); since the mid 1970s as bait for American eel (Anguilla rostrata); and since the mid 1990s as b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a8a223e045d9c5a89819fe8ff9180d3
https://doi.org/10.1007/978-3-319-19542-1_28
https://doi.org/10.1007/978-3-319-19542-1_28
Autor:
Malcolm A. Finkelman, Charles R Legg, Erik J. Paus, Paul A. Ketchum, Joanne M. Willey, Richard J. Ridge, Thomas J. Novitsky
Publikováno v:
Protein Expression and Purification. 26:202-210
Production of recombinant Limulus endotoxin neutralizing protein (rENP) was attained with the GS115 methylotrophic strain of Pichia pastoris transformed with a plasmid, bearing multiple ENP gene copies. The synthetic gene for Limulus ENP was cloned i
Publikováno v:
Journal of Endotoxin Research. 6:17-23
Endotoxin neutralizing protein (ENP) from Limulus polyphemus is an amphipathic, 11.8 kDa protein with an isoelectric point of 10.2. ENP neutralizes lipopolysaccharide (LPS) and possesses antibacterial activity against Gram-negative bacteria. Heparin
Autor:
Paul S. Graman, Edgar R. Black, Patricia L. Hibberd, Elizabeth B. Miller, Paul A. Ketchum, Richard D. Moore, David R. Snydman, Paul N. Lanken, Kenneth Sands, Jeffrey Parsonnet, J. Sanford Schwartz, Katherine L. Kahn, Thomas J. Novitsky, David W. Bates
Publikováno v:
Clinical Infectious Diseases. 27:582-591
Clinical predictions alone are insufficiently accurate to identify patients with specific types of bloodstream infection; laboratory assays might improve such predictions. Therefore, we performed a prospective cohort study of 356 episodes of sepsis s
Autor:
Thomas J. Novitsky
Publikováno v:
Annals of the New York Academy of Sciences. 851:416-421
Autor:
Marian N. Marra, Thomas J. Novitsky, Gary R. Fleisher, Richard A. Saladino, Claudette M. Thompson, Anne M. Stack, George R. Siber
Publikováno v:
Critical Care Medicine. 25:101-105
Objective: To compare a recombinant bactericidal/permeability-increasing protein variant and a recombinant endotoxin-neutralizing protein. Design: Randomized, blinded, controlled study, using a rat model of sepsis. Setting: Animal research facility.
Autor:
Thomas J. Novitsky, Gary R. Fleisher, Felicia Sattler, Anne M. Stack, Richard A. Saladino, George R. Siber, Claudette M. Thompson
Publikováno v:
Critical Care Medicine. 24:1203-1207
Objective To assess the benefit of a recombinant endotoxin neutralizing protein from Limulus polyphemus in treating Gram-negative bacterial sepsis in rabbits. Design Prospective, blinded, controlled, laboratory trial. Setting Animal research laborato
Autor:
Andrew B. Onderdonk, Brian K. Hammer, George R. Siber, Jeffrey Parsonnet, Thomas J. Novitsky, Nathan Kuppermann, Douglas S. Nelson, Claudette M. Thompson, Carmen T. Garcia, Gary R. Fleisher, Richard A. Saladino
Publikováno v:
Critical Care Medicine. 23:92-98
A recombinant endotoxin neutralizing protein was evaluated for its ability to ameliorate the effects of Escherichia coli sepsis in rats.Prospective, controlled animal trial.Hospital animal research laboratory.Wistar rats, treated with gentamicin 1 hr